文献速递炎症性肠病

亚洲炎症性肠病患者诊断后7年内骨折风险高

High Risk of Fractures Within 7 Years of Diagnosis in Asian Patients With Inflammatory Bowel Diseases.
PubMed 文献 · Clin Gastroenterol Hepatol · 2021-06-30

BACKGROUND & AIMS: In this nationwide population-based study, we investigated the risk of vertebral and hip fractures in patients with inflammatory bowel disease (IBD).…

要点

  • 新诊断炎症性肠病患者椎体与髋部骨折风险显著高于匹配对照。
  • 克罗恩病患者骨折风险更高,且不依赖糖皮质激素暴露。
  • 使用糖皮质激素进一步增加骨折风险,女性及有合并症者风险尤高。

核心结论

  • 新诊断炎症性肠病患者骨折风险显著升高,克罗恩病患者尤其明显且独立于糖皮质激素暴露。

研究设计与样本

  • 基于韩国国民健康保险理赔数据库2007-2016年的全国性人群研究,纳入新诊断炎症性肠病患者18228例(64.1%男性,65.9%溃疡性结肠炎),与年龄性别匹配对照按1:10匹配共186871例比较。

主要发现

  • 中位随访4.5年,炎症性肠病患者椎体与髋部骨折发生率为2.88/1000人年,发生率比1.24(95%CI 1.08-1.42)。
  • 使用糖皮质激素者骨折发生率比1.37(95%CI 1.13-1.65);克罗恩病患者发生率比1.56(95%CI 1.19-2.04),无糖皮质激素暴露的克罗恩病患者仍为1.62(95%CI 1.12-2.34)。
  • 骨折风险随年龄增长而升高,女性和有合并症者风险尤高。

临床怎么用

  • 对新诊断炎症性肠病患者,尤其克罗恩病、女性、高龄及有合并症者,应关注骨折风险评估。
  • 使用糖皮质激素的炎症性肠病患者需警惕骨折风险增加。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: In this nationwide population-based study, we investigated the risk of vertebral and hip fractures in patients with inflammatory bowel disease (IBD). METHODS: Using data from the Korean National Health Insurance claims database gathered between 2007 and 2016, we calculated the incidence rate ratios (IRRs) of vertebral and hip fractures in patients with newly diagnosed IBD (n = 18,228; 64.1% male, 65.9% ulcerative colitis) compared with an age- and sex-matched control population (matching ratio, 1:10; n = 186,871). RESULTS: During a median follow-up period of 4.5 years, the incidence rate and IRR of vertebral and hip fractures in patients with IBD were 2.88 per 1000 person-years and 1.24 (95% CI, 1.08-1.42), respectively. The cumulative risk of vertebral and hip fractures in IBD patients was 0.6%, 1.4%, and 1.9% at 2, 5, and 7 years after diagnosis, respectively, and this risk of fracture in IBD patients was higher than that in matched controls (P = .002). The use of corticosteroids further increased the risk of fractures in IBD patients (IRR, 1.37; 95% CI, 1.13-1.65) compared with matched controls. The risk of fractures was significantly higher in patients with Crohn's disease (CD) (IRR, 1.56; 95% CI, 1.19-2.04) than in matched controls, and this risk remained higher in patients with CD without corticosteroid exposure (IRR, 1.62; 95% CI, 1.12-2.34). The risk of fracture increased with age and was particularly high in females and in those with comorbidities. CONCLUSIONS: The risk of fractures was significantly high in newly diagnosed IBD patients, especially in those with CD regardless of corticosteroid exposure.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Ahn HJ, Kim YJ, Lee HS, et al. High Risk of Fractures Within 7 Years of Diagnosis in Asian Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2021. PMID: 34216823. doi:10.1016/j.cgh.2021.06.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。